Literature DB >> 2025175

Fibrin directs early retinal damage after experimental subretinal hemorrhage.

C A Toth1, L S Morse, L M Hjelmeland, M B Landers.   

Abstract

Subretinal blood within the macula may cause visual loss in a number of macular diseases. The clinical and histopathologic effects of experimental subretinal hemorrhage were evaluated in the cat. Subretinal hemorrhages were produced by creating a focal neurosensory retinal detachment with micropipette techniques, then inserting a needle tip transsclerally to allow choroidal blood to fill the bleb. Experimental lesions were examined clinically and with light and electron microscopy during a 14-day postoperative period. Initial observations included clot organization with retraction of fibrin strands. In six of nine clots more than 1 hour old, fibrin was associated with tearing of sheets of photoreceptor inner and outer segments. Later degeneration progressed to involve all retinal layers overlying the densest areas of fibrin in the clots. Hemorrhages into subretinal blebs containing tissue plasminogen activator did not form fibrin strands or cause photoreceptor tearing. These findings highlight the potential for improved retinal survival if organized subretinal clot can be eliminated soon after formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025175     DOI: 10.1001/archopht.1991.01080050139046

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  70 in total

1.  Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration.

Authors:  M A Nasir; I Sugino; M A Zarbin
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  [Subretinal co-application of rtPA and bevacizumab for exudative AMD with submacular hemorrhage. Compatibility and clinical long-term results].

Authors:  J Hillenkamp; A Klettner; S Puls; F Treumer; J Roider
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

3.  Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.

Authors:  Muhammet Kazim Erol; Berna Dogan; Deniz Turgut Coban; Devrim Toslak; Ayse Cengiz; Deniz Ozel
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.

Authors:  Jost Hillenkamp; Vladimir Surguch; Carsten Framme; Veit-Peter Gabel; Helmut G Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

5.  Management of macular hole and submacular hemorrhage in the same eye.

Authors:  Sophie J Bakri; Jonathan E Sears; Hilel Lewis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-27       Impact factor: 3.117

6.  Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

Authors:  Jae Hui Kim; Young Suk Chang; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2017-11-29       Impact factor: 2.447

7.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

8.  Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy.

Authors:  J H Kim; Y S Chang; J W Kim; C G Kim; D W Lee
Journal:  Eye (Lond)       Date:  2017-07-14       Impact factor: 3.775

9.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

10.  Early-onset macular holes following ruptured retinal arterial macroaneurysms.

Authors:  Rina Sato; Tsutomu Yasukawa; Yoshio Hirano; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.